Company Filing History:
Years Active: 2017-2018
Title: Innovations by Qingqin S Li in Depression Treatment and Cancer Response
Introduction
Qingqin S Li is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the fields of mental health and oncology through his innovative patents. With a total of 2 patents, his work focuses on improving treatment methodologies for depression and cancer-related neurological issues.
Latest Patents
One of his latest patents is a method for the treatment of depression. This invention specifically addresses treatment-resistant depression by adjusting the treatment regimen based on the patient's genotype at SNP rs4306882. Another important patent involves biomarkers for assessing peripheral neuropathy response to cancer treatment. This invention provides methods for identifying patients at increased risk of developing adverse neurological events in response to cancer treatments. It also includes modifying the treatment regimen based on the presence or absence of biomarkers in the patient.
Career Highlights
Qingqin S Li is currently associated with Janssen Pharmaceutica NV, where he continues to work on groundbreaking research and development in the pharmaceutical industry. His expertise in the intersection of genetics and treatment responses has positioned him as a valuable asset in his field.
Collaborations
He has collaborated with notable colleagues such as Wayne C Drevets and Nadine Cohen, contributing to a rich environment of innovation and research.
Conclusion
Qingqin S Li's contributions to the treatment of depression and cancer response highlight his role as a leading inventor in the pharmaceutical industry. His innovative approaches are paving the way for more personalized and effective treatment options.